Ortho Biotic is a unique probiotic formula designed to
deliver active organisms shown to promote healthy gut
microflora, protect intestinal integrity and boost immune
function. Included in this formula is Saccharomyces
boulardii, an extensively researched microorganism shown
to help restore microflora balance by enhancing commensal
organism function. Each Ortho Biotic capsule provides seven
proven probiotic strains chosen for their ability to withstand
the harsh gastrointestinal (GI) environment and adhere to
the intestinal tract to deliver superior results.
The GI tract is a finely balanced environment where roughly 500
different strains of bacteria compete for space and nutrients.
When there is a healthy balance (eubiosis), few symptoms
exist. However, dysbiosis can occur when an overabundance
of potentially harmful organisms prevail. The natural microflora
balance can be upset by medications (such as antibiotics, oral
contraceptives, etc.), excessive alcohol consumption, or poor
Probiotics have been extensively studied and are characterized
as having broad GI and immune benefits, including (1)
increasing the population of healthy bacteria following
microflora imbalance; (2) supporting healthy bowel function;
(3) increasing the production of short-chain fatty acids,
which provide energy to the cells of the intestinal lining; (4)
strengthening the gut-immune barrier by promoting a healthy
gut mucosa; (5) aiding in the digestion of difficult-tobreakdown
compounds like lactose and casein; and (6)
enhancing detoxification of harmful compounds.
Because probiotics are live organisms, there are many
challenges associated with manufacturing and distributing
probiotic supplements. For a probiotic to be effective, it must
be shelf-stable through the expiration date and precisely
delivered to the intestinal tract, where it can have maximum
benefit. BioShield® technology is an innovative manufacturing
process developed to ensure consistent and reliable results.
The microorganisms in Ortho Biotic are protected, sealed and
freeze dried away from moisture, heat, light and oxygen. This
allows the bacteria to remain dormant until they are exposed
to moisture in the GI tract. By utilizing advanced encapsulation
technology, the probiotic organisms are preserved and
released on-target for maximum benefit.
Lactobacillus acidophilus (La-14†
Lactobacillus acidophilus is a beneficial bacterial strain that
is normally found in the intestinal tract and mouth and is
commercially used in dairy products for the production of
acidophilus-type yogurt. L. acidophilus ferments various
carbohydrates to produce lactic acid, which increases the
absorption and bioavailability of minerals. This includes
calcium, copper, magnesium and manganese. The production
of lactic acid also promotes health by creating an inhospitable
environment for invading microbes.1 L. acidophilus has been
shown to protect intestinal cells by competing for adhesion
space in the gut against harmful bacteria, such as E. coli. The L.
acidophilus strain in Ortho Biotic has been specifically chosen
because of its strong adherence and survival attributes in the
GI tract. It has been demonstrated in vitro to tolerate exposure
to gastric acid and bile salts, and has the ability to withstand
antibiotics including Ciproflaxin, Polymyxin B and Tetracycline.2
Lactobacillus paracasei (Lpc-37)†
Lactobacillus paracasei has been shown to protect against
the harmful effects of bacteria such as Staphylococcus aureus
(S. aureus).3 L. paracasei colonizes the intestinal tract by
reinforcing defense mechanisms that support an immune
response. It does this by supporting T-helper cell production
and secreting secretory IgA (sIgA), an antibody critical for
supporting intestinal immunity.4
L. paracasei Lpc-37 is a gastric
acid-resistant strain and has been shown in vitro to withstand
antibiotics such as Ciproflaxin and Vancomycin.5
Bifidobacterium bifidum (Bb-06)†
Bifidobacterium bifidum has been shown to effectively
compete with harmful bacteria such as E. coli, S. aureus and
Camplylobacter jejuni, which suggests B. bifidum’s lactic acid
and acetic acid production provides an antagonistic action
against pathogens to help maintain microflora balance.6
Bifidobacterium lactis (BI-04)†
Bifidobacterium lactis is predominantly found in the colon. A
double-blind, randomized placebo-controlled trial on subjects
receiving B. lactis or placebo for eight weeks found that B.
lactis supported a balanced immune response in individuals
hypersensitive to environmental allergens.7
Studies examining immune development and dietary supplementation with
B. lactis have shown that it supports GI health by reducing
Lactobacillus plantarum (Lp-115)†
Lactobacillus plantarum is a beneficial bacteria commonly
found in fermented foods including sauerkraut, pickles,
brined olives and sourdough. L. plantarum has been found to
compete against strains of Clostridium difficile and Clostridium
perfringens, due to the production of bacteriocins (lethal
proteins) that inhibit bacterial growth.9
Studies have also
demonstrated that L. plantarum helps boost the immune
response by stimulating Th1-mediated immunity.10
Lactobacillus rhamnosus (Lr-32)†
Lactobacillus rhamnosus has been proven to have remarkable
survivability in the acid and bile environments in the GI tract. L.
rhamnosus is particularly useful because of its ability to adhere
to cells, enhance microflora balance, and inhibit pathogen
adherence. L. rhamnosus was also found to positively affect
inflammatory and immune gene signaling of over 1,700 genes
when administered in high doses.10
Saccharomyces boulardii is a probiotic yeast that was first
isolated from the skin of the tropical fruits lychee and
mangosteen in 1923 by French scientist Henri Boulard,
following the observation that mangosteen consumption
controlled occasional diarrhea in natives of Southeast Asia.
S. boulardii plays a role in supporting immune defense by
increasing levels of sIgA, creating a first line of defense that
helps bind and clear harmful bacteria.11
1 capsule per day or as recommended by your health care
Does Not Contain
Wheat, gluten, soy, corn, animal or dairy products, fish,
shellfish, peanuts, tree nuts, egg, artificial colors, artificial
sweeteners or preservatives.
If you are pregnant or nursing, consult your physician
before taking this product.
1. Lipski E. Digestive Wellness. New Canaan (CT): Keats Publishing; 1996. p. 60-61.
2. Danisco. Lactobacillus acidophilus La-14 probiotic identity card.
3. Bendali F, Madi N, Sadoun D. Beneficial effects of a strain of Lactobacillus paracasei subsp. paracasei in Staphylococcus aureus-induced intestinal and colonic injury. Int J Infect Dis. 2011 Nov;15(11):e787-94.
4. Chiang SS, Pan TM. Beneficial effects of Lactobacillus paracasei subsp. paracasei NTU 101 and its fermented products. Appl Microbiol Biotechno. 2012 Feb;93(3):903- 16.
5. Danisco. Lactobacillus paracasei Lpc-37 probiotic identity card.
6. Singh A, Hacini-Rachinel F, Gosoniu ML, Bourdeau T, Holvoet S, Doucet-Ladeveze R, Beaumont M, Mercenier A, Nutten S. Immune-modulatory effect of probiotic Bifidobacterium lactis NCC2818 in individuals suffering from seasonal allergic rhinitis to grass pollen: an exploratory, randomized, placebo-controlled clinical trial. Eur J Clin Nut. 2013 Feb;67(2):161-7.
7. Lewis MC, Patel DV, Fowler J, Duncker S, Zuercher AW, Mercenier A, Bailey M. Dietary supplementation with Bifidobacterium lactis NCC2818 from weaning reduces local immunoglobulin production in lymphoid-associated tissues but increases systemic antibodies in healthy neonates. Br J Nutr. 2013 Oct;110(7):1243-52.
8. Schoster A, Kokotovic B, Permin A, Pedersen PD, Bello FD, Guarabassi L. In vitro inhibition of Clostridium difficile and Clostridium perfringens by commercial probiotic strains. Anaerobe. 2013 Apr; 20:36-41.
9. Chytilová M, Mudroňová D, Nemcová R, Gancarčíková S, Buleca V, Koščová J, Tkáčiková L. Anti-inflammatory and immunoregulatory effects of flax-seed oil and Lactobacillus plantarum - Biocenol™ LP96 in gnotobiotic pigs challenged with enterotoxigenic Escherichia coli. Res Vet Sci. 2013 Aug;95(1):103-9.
10. Evard B, Coudeyras S, Dosgilbert A, Charbonnel N, Alamé J, Tridon A, Forestier C. Dose-dependent immunomodulation of human dendritic cells by the probiotic Lactobacillus rhamnosus Lcr35. PLoS ONE. 2011 Apr 18;6(4):e18735.
11. Rodrigues AC, Cara DC, Fretez SH, Cunha FQ, Vieira EC,
Nicoli JR, Vieira LQ. Saccharomyces boulardii stimulates
sIgA production and the phagocytic system of gnotobiotic
mice. J Appl Microbiol. 2000 Sep;89(3):404-14.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.